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Abstract 
Introduction: Feeling pain after root canal therapy has always been a major problem for patients 
and dentists. One of the suggested methods to manage the pain is using the prophylactic 
medication before treatment process. This study aimed at investigating the comparison of 
pretreatment with novafen versus gelofen on reducing the pain after root canal therapy. 
Materials &Methods: This double-blind randomized clinical trial study was conducted on 60 
patients aged 18-65 who were indicated for root canal therapy. Patients were randomly assigned to 
receive gelofen capsules (400mg), novafen capsules (200mg) and placebo two capsules by every 
patient of these groups one hour prior to sampling. Pre/post-treatment pain was measured using 
Visual Analog Scale (VAS) before treatment and 4, 8, 12, 24 and 48 hours after treatment. 
Results: Both novafen and gelofen indicated significant analgesic effect during the study period 
(p<0.001). Pain severity within 8 hours after treatment was significantly lower in novafen group 
than two other groups (p=0.03). The difference between the severity of pain did not show any 
association to their place of life and gender in any groups. 
Conclusion: Our findings revealed that the prophylactic novafen in comparison to gelofen had a 
better analgesic effect in short-term and could be a good candidate for the management of post-
endodontic treatment pain. 
Keywords: Pain, Root canal therapy, Tooth root, Dentists, Patients 
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 ؛کیتويديدوا نامرد زا سپ درد هیکست رب هفاًو ي هفًلژ اب یوامرد صیپ یبایزرا 
رًک ًس يد یىیلاب ییامزآراک ٍعلاطم کی  
 
،ماکژد یدُم دیس دمحم داژو یفضاک، ،دار ییازریم اىیس ،ایو مدقم ربکا یلع ایو یلق تمَ 
 
ٌدیکچ 
ٍمدقم:  سا یکی .ددزگ یه بَسحه ىاکضشپًاذًد ٍ ىاراویب ُذوع تلاکطه سا ُراَوّ ىاذًد ِطیر ىاهرد سا سپ درد ساسحا
ا یکضشپاذًد ِلخاذه سا لبق یًاهرد صیپ ، درد سا یزیگطیپ تْج ُذض داٌْطیپ یاّراکّار صیپ ِسیاقه فذّ اب زضاح ِعلاطه .تس
.تسا ىاذًد ِطیر ىاهرد سا سپ درد لزتٌک رد يفَلص اب ِسیاقه رد يفاًَ اب یًاهرد 
:اَ شير ي داًم  یٍر زب رَک َس ٍد ُذض یفداصت یٌیلاب ییاهسآراک شٍر ِب زضاح ِعلاطه06  یٌس ُساب اب راویب06-60  ِک لاس
اد ار ىاذًد ِطیر ىاهرد ىَیساکیذًا لَسپک( يفَلص ٍُزگ .ذًذض نیسقت ٍُزگ ِس ِب یفداصت ترَصب ىاراویب .تفزیذپ ترَص ذٌتض
066  لَسپک (يفاًَ ٍُزگ  ،)مزگ یلیه066  لَسپک دذع ٍد یًاهرد ِلخاذه سا لبق تعاس کی راویب زّ ِک َبسلاپ ٍُزگ ٍ )مزگ یلیه
 ٍ لبق رد ىاشیه .دَوً یه تفایرد ار0،8 ،60 ،00ٍ 08 سا سپ تعاس  سایقه سا ُدافتسا اب ىاهردVAS .ذیدزگ تبث راویب زّ طسَت 
:اَ ٍتفای ( ذٌتضاد ِعلاطه ُرٍد لَط رد یراد یٌعه یدرد ذض تازثا يفاًٍَ ٍ يفَلص0.001>p تذض يفاًَ ٍُزگ رد يیٌچوّ )
 درد8 تسا ِتضاد راد یٌعه فلاتخا اّ ٍُزگ زیاس ِب تبسً ىاهرد سا سپ تعاس(0.03=p)  تذض یفزط سا ٍ سٌج ٍد ىایهرد درد
.تسا ِتضاذً راد یٌعه فلاتخا ىاراویب تًَکس لحه 
:یریگ ٍجیتو  ٍ دراد يفَلص اب ِسیاقه رد تذه ُاتَک رد یزتطیب یدرد ذض تازثا يفاًٍَ اب یًاهرد صیپ ُذهآ تسذب جیاتً ساسا زب
زگ حزطه کیتًٍدٍذًا لاوعا سا سپ یاّدرد صّاک رد باختًا کی ىاٌَع ِب ذًاَت یه.دد 
:یدیلک ناگژاي ،ىاذًد ِطیر،ِطیر ىاهرد ،درد ىاراویب ،ىاکضشپًاذًد 
 
Introduction 
Pain and anxiety that sometimes happen during 
dental treatment need to be considered properly. [1] 
Endodontic procedures are usually performed without 
any pain during the treatment, but there is a possibility 
of experiencing pain after treatment. In a clinical study, 
7 %, 15 % and   21 % of patients had severe, moderate 
and weak pain, respectively after root canal therapy. 
[2]
Complaining about pain or flare-up after treatment 
was reported in those with feeling pain before 
beginning the procedure. Therefore, people who 
usually suffer from pain after treatment are the same 
individuals that are complaining about pain before 
treatment. For the tooth pain and particularly the pain 
after endodontic root canal is the use of analgesics 
including: Non-Steroidal Anti Inflammatory Drugs 
(NSAIDs) and acetaminophen are the most frequent 
administered drugs.
[2] 
According to the immunological 
and histological studies, cyclooxygenase-2 enzyme  
 
exists in human dental pulp and inflamed pulp contains 
cells that contain cyclooxygenase-2, while very few of 
these cells are found in normal pulp. NSAIDs are the 
kind of drugs that act as controller of inflammatory 
pain by binding to plasma proteins. 
[3,4]
 On the other 
hand, these drugs could have undesirable side effects 
such as one of the gastrointestinal discomforts due to 
their restraining property on cyclooxygenase enzyme. 
The expression of mucin proteins which protect the 
intestinal mucosal cell growth was suppressed by non-
selective NSAIDs and this expression was restored by 
PGE2. 
[5] 
Gelofen is a derivation of propionic acid and 
a member of anti-inflammatory non-steroidal drugs 
(NSAIDs) classification. Gelofen is used in curing 
weak to moderate pain, inflammation after surgery, 
dental pain and migraine. Gelofen has less 
gastrointestinal impacts than other NSAIDs; however, 
it can causes abdominal pain, nausea, vomiting, 
gastrointestinal bleeding and ulcers of the small 
intestine, Novafen is a compound drug containing 325 
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mg acetaminophen, 200 mg ibuprofen and 40 mg of 
caffeine. 
[6]
 Acetaminophen affects the central and 
peripheral nerve system. Ibuprofen has also an anti-
inflammatory effect. Caffeine is also a narcotic 
analgesic. 
[7]
 Several studies have been performed and 
evaluated on the impacts of analgesics on pain after 
endodontic therapy. In most of the studies, prescribing 
drugs were suggested after starting endodontic 
treatment 
[8]
; but still the best pre-treatment choice for 
pain management is a matter of controversy. Thus, we 
aimed to compare the effect of pretreatment with 
gelofen versus novafen in the management of the post 
endodontic pain relief. 
 
 
Methods  
This double-blind randomized placebo clinical 
trial study was performed on 60 patients who referred 
to the endodontic department in Babol University of 
Medical Sciences in the first semester of 2013-2014. 
The protocol was approved by research review board, 
Babol University of Medical Sciences, Babol, Iran and 
registered in Iranian Clinical Trials Registry (IRCT id: 
IRCT 2014041316973N2). All the patients were 
indicated for root canal therapy. The inclusion criteria 
of the study were having age range of 18 to 65 years 
old, no use of any other analgesic during treatment 
process or 12 hours before starting medication, having 
the ability of reading, understanding and filling the 
questionnaire, having teeth with alive pulps and no 
periapical lesion. The exclusion criteria of the study 
were as follows: having systemic diseases (Lupus, 
Diabetes mellitus etc), renal, nervous, heart or liver 
diseases, cancer or severe abnormalities, allergy to 
NSAIDs, pregnancy or lactation, alcohol consumption, 
uncontrolled hypertension, current smokers. 
After explaining the objectives of the study and 
obtaining the written informed consent, the process 
was started by endodontic students. Groups, each 
containing 20 subjects, were randomly assigned to 
receive gelofen capsule (400 mg; by Zakaria Tabriz 
Pharmaceutica), novafen capsule (200 mg; by Darou 
Pakhsh Tehran Holding Co.) and placebo (containing 
flour and starch), all of them were packaged in 
identical 500 mg capsules with the same color and size 
and then encoded by a third person unaware of the 
study protocol. Each participant received a package 
containing 2 capsules and consumed them 60 minutes 
before sampling. They were obligated not to take any 
pain relief or other medication, but in the case of acute 
pain, they were allowed to take acetaminophen codeine 
that should be reported in their next visit. Explanation 
about the pain after 24 and 48 hours were also recorded 
in their document that including: spontaneous pain, 
acute pain, or no pain. According to double-blind study 
design, both the patient and the dentist were not aware 
of the type of random a location. They underwent the 
root canal therapy including cavity preparation, 
cleaning and preparing all the canals until the canals 
were ready to be filled. All the teeth tried to be cleaned 
at once and canal obturation was performed at the same 
time. The canals were antisepticised by normal saline 
(physiological saline solution) and then the teeth were 
dressed by Cavite. Lidocaine (2%) and epinephrine 
1/800000 were used for local anesthesia. AH26 was 
used as sealer. Cleaning the canals was performed by 
step-back method and canals were filled using lateral 
technique.  
Visual Analog Scale (VAS) criteria were used to 
evaluate and determine the pain severity before 
beginning the treatment and also the pain relief after 
treatment. A pain assessment form was given to each 
patient. Then, they were informed about the method of 
explaining their pain intensity by using digits 0 to 10 (0 
for no pain and 10 for the highest severity of pain) by 
considering the time. Reckoned times after performing 
treatment in the application were 4, 8, 12, 24, and 48 
hour, respectively.  At the end of process, the data were 
analyzed by SPSS 18 software and VAS pain scores 
were compared using one-way ANOVA and post hoc 
Tukey test. P less than 0.05 was considered as 
statistical significance.  
 
 
Results 
In a total of 60 patients, 24 (40%) were men and 
36(60%) were women. Forty one (68.3%) and 19 
(31.7%) participants were living in urban and rural 
areas, respectively. Mean and standard deviation of the 
age of the participants in the Novafen, Gelofen, and 
placebo groups were 36.5±12.72, 31.3±9.95 and 
41.35±13.14 years old, respectively. No significant 
difference was found in distribution of genders 
between groups (p=0.15). As indicated in table 1, the 
mean severity of pain was reported based on VAS 
concerning the time of taking the drug in three groups. 
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The pain severity after 8 hours was significantly lower 
in novafen group compared to other groups (gelofen 
and placebo) (p=0.03). Mean intensity of the pain in 
groups taking gelofen and novafen compared to 
placebo over 12 hours and 48 h was lower after 
treatment but there  was  no  significant  difference  
among three groups which  indicated  that there was no 
long term analgesic effect than the placebo. According 
to repeated measures analysis, pain decreased in all 
three groups after treatment (p<0.001). The trend of 
reducing the pain intensity within 48 hours among 
studied groups was displayed in figure1. 
In addition, the difference between the severity of 
pain did not show any association to their place of life 
and gender in any groups. 
 
Table1. Mean severity of pain in studied groups based on VAS  
 
48 hours after 
treatment 
24 hours after 
treatment 
12 hours after 
treatment 
8 hours after 
treatment 
4 hours after 
treatment 
Before 
treatment 
Group 
1±1.02 1.75±1.74 2.55±1.35 1.75±1.25 2.7±1.3 5.55±1.14 Novafen 
0.7±0.73 1.65±1.08 2.8±1.43 2.45±0.88 3.25±1.51 5.95±1.31 Gelofen 
1±1.33 1.8±1.67 3.4±1.6 2.5±0.68 2.35±1.755 5.15±1.03 placebo 
0.59 0.95 0.18 0.03 0.16 0.1 p-value 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1. Mean of VAS changes by time in three study groups 
 
Discussion  
The present study indicated that comparing the 
placebo, gelofen and novafen showed a significant 
effect on reducing the pain after root canal therapy. 
Previous studies investigated the pain killer 
consumption before the root canal therapy and 
documented significant results which were consistent 
with our findings. 
[9-11]
  According to our findings, 8 
hours after root canal therapy, the analgesic effect in 
novafen group was significantly higher than two other 
groups, but novafen effect was almost the same after  
12, 24 and 48 hours long-term follow up. Arsalan et al.  
revealed that 6-hour period, both 20 mg of tenoxicam  
 
and 200 mg of ibuprofen provided significantly 
better pain relief than the placebo. 
[12]
 In a similar study 
prophylactic ibuprofen administration significantly 
reduced postendodontic pain at 4 and 8 h after 
initiation of root canal therapy in compare with 
etodolac and a placebo. 
[13] 
Also, Wells et al. compared 
the use of ibuprofen versus ibuprofen/acetaminophen 
for postoperative endodontic pain in a randomized 
double-blind study and found that there were decreases 
in pain levels and analgesic use over time for both 
groups.
[14]
 Most studies suggested that the pain 
intensity reached to the highest level after 24 to 48 
0
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hours. 
[12, 15]
 Therefore, we mostly focused on the 
determination of pain intensity after 48 hours. In the 
current study, the pain intensity decreased in all 
groups, which was statistically significant and showed 
that root canal therapy was independently efficient for 
decreasing the pain. Novafen is a compound drug that 
its prophylactic property can decrease the pain after 
root canal therapy and in comparing with gelofen has a 
significant effect on reducing the short-time 
postoperative pain.  
Although among the studied populations there was 
no significant side effect mentioned by the subjects, 
long term use of these drugs may arise some levels of 
common side effects such as: nausea and dizziness, 
headache, gastrointestinal discomfort and etc. 
However, previous studies did not report any 
significant difference between groups in their short 
term period. 
[16,17]  
We  encountered several  limitations  
in  this  study  in  regard  to  the  small  sample  size  
and duration of  the  study period. Future RCT studies 
with larger sample size are suggested to reach more 
valid results. 
 
Conclusion  
Considering the findings of the present study, 
pretreatment with novafen in comparison to gelofen 
reduced the severity of pain, and novafen could be 
suggested for short-term pretreatment for post 
endodontic procedures. 
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